Xalatan and Increased tendency to bruise - a phase IV clinical study of FDA data

Summary:

Increased tendency to bruise is reported as a side effect among people who take Xalatan (latanoprost), especially for people who are male, 60+ old, also take Esbriet, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Increased tendency to bruise when taking Xalatan. It is created by eHealthMe based on reports of 25,196 people who have side effects when taking Xalatan from the FDA, and is updated regularly.

What is Xalatan?

Xalatan has active ingredients of latanoprost. It is often used in glaucoma. eHealthMe is studying from 25,550 Xalatan users. Check the latest studies of Xalatan.

What is Increased tendency to bruise?

Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone) is found to be associated with 770 drugs and 813 conditions by eHealthMe. Check the latest studies of Increased tendency to bruise.

On Jul, 08, 2026

25,196 people reported to have side effects when taking Xalatan.
Among them, 15 people (0.06%) have Increased tendency to bruise.

Could Xalatan cause Increased tendency to bruise?

Among these 15 people:

What is the gender of people who have Increased tendency to bruise when taking Xalatan? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Increased tendency to bruise when taking Xalatan? *

What are other drugs people take besides Xalatan? *

What are other side effects people have besides Increased tendency to bruise? *

Fatigue (feeling of tiredness): 10 people, 66.67%
Joint Pain: 7 people, 46.67%
Fall: 7 people, 46.67%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 6 people, 40.00%
Hypoacusis (loss of hearing): 5 people, 33.33%
Broken Bone: 5 people, 33.33%
Hearing Loss: 5 people, 33.33%
Weight Increased: 5 people, 33.33%
Heart Rate Increased: 5 people, 33.33%
Thermal Burn (burn by heat): 5 people, 33.33%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 46.67%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 6 people, 40.00%
Pneumonia: 5 people, 33.33%
Interstitial Lung Disease: 5 people, 33.33%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 13.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.67%
Pain: 1 person, 6.67%
Osteoporosis (bones weak and more likely to break): 1 person, 6.67%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 6.67%
Insomnia (sleeplessness): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Xalatan and have Increased tendency to bruise?

- Check whether Increased tendency to bruise is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xalatan:

Xalatan (25,550 reports)

Browse all side effects of Xalatan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Increased tendency to bruise:

Increased tendency to bruise (770 drugs)

Browse all the conditions that are associated with Increased tendency to bruise:

Increased tendency to bruise (813 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on latanoprost (the active ingredients of Xalatan) and Xalatan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.